Facts about LEO Pharma

This is a compilation of fast facts about LEO Pharma. If you require further information, please refer to our media contact.

What - focus areas, products, pipeline and financial figures

Where – headquarters, global presence and production plants.

When - LEO Pharma history in brief

Who - management structure, the LEO Foundation and LEO people. 


LEO Pharma is a Danish research-based pharmaceutical company wholly owned by The LEO Foundation, an independent, mercantile foundation.

Read more in the LEO Fundamentals.

Focus Areas


  • Psoriasis
  • Eczema
  • Skin infections
  • Actinic keratosis and non-melanoma skin cancer

Critical Care:

  • Thrombosis
  • Nephrology
  • Supportive treatment in cancer


Read more about our Products.

View the most recent version of the LEO Pharma Pipeline.


Read more about the LEO pipeline

Financial Figures

Group turnover

2009: DKK 6,081.5 million
2008: DKK 5,709.4 million
2007: DKK 5,245.9 million
2006: DKK 5,176.3 million

Profit before tax

2008: DKK 3,222.8 million
2007: DKK 2,901.2 million
2006: DKK 3,015.9 million

Net Profit

2008: DKK 2,528.2 million
2007: DKK 2,364.5 million
2006: DKK 2,431.2 million

Read more about LEO Pharma Financial Figures

Read more about LEO financial figures 
LEO financial figures 2004-2008.


LEO Pharma is headquartered in Denmark.


LEO Pharma is headquartered in Ballerup, Denmark:

LEO Pharma A/S
Industriparken 55
DK-2750 Ballerup

CVR No. 56759514

Tel: +45 44 94 58 88
Fax: +45 72 26 33 21


Contact LEO Pharma headquarters.

Get more details about visiting LEO Pharma, Ballerup, Denmark. 

Global presence

LEO People and offices in 54 countries. 
Products sold in 100 countries.

You can find the LEO Pharma office nearest to you on the map below.


See LEO global presence
See LEO global presence.

Production Plants

Production Plants in:

  • Ballerup - Denmark
  • Esbjerg - Denmark
  • Vernouillet, Dreux - France
  • Dublin - Ireland
  • Wexport, Cork - Ireland.

Get details about LEO Production plants.


LEO was established in 1908 in Denmark.

In November 2008, LEO Pharma celebrated its 100th anniversary. LEO Pharma was the first company outside the UK and the US to produce penicillin.

Read more about the LEO History




Read more about the LEO ManagementRead more about the LEO Management


3,500 employees worldwide - approx. 1,300 of these based in the headquarters in Ballerup, Denmark.

  • Research & Development: >500
  • Global Product Supply: >950
  • Sales & Marketing: >1900
  • Support functions: approx. 150

(Full-time equivalent. Ultimo 2009)

LEO People form the basis for the continuous success of LEO Pharma and LEO actively supports diversity and encourages the continuous development of LEO People’s professional skills.

Read more about being employed at LEO Pharma and current Job openings.

Read more about the LEO values in the LEO Fundamentals.

LEO Foundation

LEO Pharma is wholly owned by The LEO Foundation, an independent, mercantile foundation. 

The objective of the LEO Foundation is to ensure that LEO Pharma, through continuous development and growth, remains an independent and competitive pharmaceutical company.

Read about the LEO Foundation

Box 2